Clinical Trial Update: Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Xeomin (botulinum toxin type A) for expression wrinkles in the upper face has completed, with results posted in December 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Aging

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Biolab Sanus Farmaceutica | Conditions: Skin Aging | Phase 3 | Status: COMPLETED | Results posted: 2010-12-06